share_log

Pfizer | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)

Pfizer | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)

辉瑞 | SC 13D/A：超过5%持股股东披露文件(修正)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)
美股sec公告 ·  07/29 16:36
Moomoo AI 已提取核心信息
On July 29, 2024, Pfizer Inc. entered into a share purchase deed with Haleon PLC, providing a framework for off-market purchases of Haleon's ordinary shares by Pfizer. The agreement allows for purchases on multiple occasions, either in conjunction with future share offerings by Pfizer or as standalone transactions. The share purchase deed does not obligate either party to proceed with any purchase, and either Pfizer or Haleon may decline participation at their discretion. The terms of the deed will remain in effect until the approval of Haleon's shareholders expires and is not renewed at a subsequent annual general meeting. The transaction is subject to certain conditions, including shareholder approval, price range restrictions, and compliance with related party transaction rules...Show More
On July 29, 2024, Pfizer Inc. entered into a share purchase deed with Haleon PLC, providing a framework for off-market purchases of Haleon's ordinary shares by Pfizer. The agreement allows for purchases on multiple occasions, either in conjunction with future share offerings by Pfizer or as standalone transactions. The share purchase deed does not obligate either party to proceed with any purchase, and either Pfizer or Haleon may decline participation at their discretion. The terms of the deed will remain in effect until the approval of Haleon's shareholders expires and is not renewed at a subsequent annual general meeting. The transaction is subject to certain conditions, including shareholder approval, price range restrictions, and compliance with related party transaction rules under the Listing Rules. Pfizer, incorporated in Delaware, holds a significant number of Haleon's ordinary shares, and the agreement could potentially involve a considerable percentage of Haleon's issued share capital. The share purchase deed was executed as part of Amendment No. 8 to the Schedule 13D filed with the SEC, amending and supplementing previous disclosures.
2024年7月29日，辉瑞公司与海蓝公司(Haleon PLC)签署了一份股份购买协议，为辉瑞公司非上市购买海蓝公司普通股提供了框架。协议允许在多个场合购买，可以与辉瑞未来的股票发行相结合或作为独立交易。股份购买协议并不强制双方进行任何购买，辉瑞或海蓝均可自行决定是否参加。该协议的条款将持续有效，直到海蓝公司股东的批准到期，并且在随后的股东年度大会上不予续订。交易受到某些条件的限制，包括股东批准、价格范围限制以及符合上市规则下相关当事人交易规定等。总部位于特拉华州的辉瑞公司持有海蓝公司的大量普通股，此协议可能涉及海蓝公司已发行股份的相当比例。股份购买协议是作为提交给美国证券交易委员会(Securities and Exchange Commission，SEC)的第13D附表第8修改议案的一部分执行，以修改和补充先前的披露。
2024年7月29日，辉瑞公司与海蓝公司(Haleon PLC)签署了一份股份购买协议，为辉瑞公司非上市购买海蓝公司普通股提供了框架。协议允许在多个场合购买，可以与辉瑞未来的股票发行相结合或作为独立交易。股份购买协议并不强制双方进行任何购买，辉瑞或海蓝均可自行决定是否参加。该协议的条款将持续有效，直到海蓝公司股东的批准到期，并且在随后的股东年度大会上不予续订。交易受到某些条件的限制，包括股东批准、价格范围限制以及符合上市规则下相关当事人交易规定等。总部位于特拉华州的辉瑞公司持有海蓝公司的大量普通股，此协议可能涉及海蓝公司已发行股份的相当比例。股份购买协议是作为提交给美国证券交易委员会(Securities and Exchange Commission，SEC)的第13D附表第8修改议案的一部分执行，以修改和补充先前的披露。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息